High-sensitivity C-reactive protein in high-grade carotid stenosis: Risk marker for unstable carotid plaque

Journal of Vascular Surgery

Volumn 38, Issue 5, 2003, Pages 1018-1024

  Alvarez Garcia, Beatriz ^a   Ruiz, Carmen ^b   Chacon, Pilar ^b   Alvarez Sabin, Jose ^b   Matas, Manuel ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CYTOLOGY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0242575853     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(03)00709-2     Document Type: Article

References (34)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
2. Van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
3. Carr S, Farb A, Peirce WH, Virmani R, F, Yao JST. Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis. Surgery 1997;122:757-64.
4. Whihelmsen L, Svärdsudd K, Korsan-Bengsten K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-5.
5. Neumann FJ, Katus HA, Hoberg E, Roebruck P, Braun M, Haupt HM. Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable clinical outcome in patients with unstable angina. Br Heart J 1991;66:425-30.
6. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
7. Maury CPJ, Totterman KJ, Gref C-G, Ehnholm C. Serum amyloid A protein, apolipoprotein A-I and apolipoprotein B during the course of acute myocardial infarctation. J Clin Pathol 1988;41:1263-8.
8. Schultz DR, Arnold PL. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein and fibrinogen. Semin Arthritis Rheum 1990;20:129-47.
9. Ridker PM, Cushman M, Stampfer MJ, Tracy RP. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
10. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable patients. Lancet 1997;349:462-6.
11. Toss H, Lindhal B, Siegbahn A, Wallentin L, for the FRISC Study Group. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 1997;96:4204-10.
12. Doggen CJM, Berckmans RJ, Sturk A, Manger V, Rosendaal FR. C-reactive protein, cardiovascular risk factors and the association with myocardial infarction in men. J Intern Med 2000;248:406-14.
13. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-8.
14. Van Exel E, Gusseklov J, de Craen AJM, Bootsma van der Wiel A, Frölich M, Westendorp RGJ. Inflammation and stroke: the Leiden 85-Plus Study. Stroke 2002;33:1135-8.
15. Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001;32:133-8.
16. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-reactive protein and outcome after ischemic stroke. Stroke 1999;30:981-5.
17. Nakagomi A, Freedman SB, Geczy CL. Interferon-(gamma) and lipopolysaccharide potentiates monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment. Circulation 2000;101:1785-91.
18. Torzewski M, Rist C, Mortesen R, Zwaka T, Bienek M, Waltenberg J, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscl Thromb Vasc Biol 2000;20:2094-105.
19. NASCET Investigators. Clinical alert: benefit of carotid endarterectomy for patients with high-grade stenosis of the internal carotid artery. National Institute of Neurological Disorders and Stroke, Stroke and Trauma Division. North American Symptomatic Carotid Endarterectomy Trial. Stroke 1991;22:816-7.
20. Fernández Valenzuela V, Bellmunt Montoya S, Escribano Ferrer JM, Juan J, Allegue N, Matas M. Carotid endarterectomy without angiography. Rev Neurol 2000;31:412-6.
21. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;15:1512-31.
22. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994;90:775-8.
23. Hansonn GK, Jonasson L, Holm J, Clowes A. Gamma interferon regulates vascular smooth muscle proliferation and expression in vivo and in vitro. Circ Res 1988;63:712-9.
24. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
25. Zukowski AJ, Nicolaides AN, Lewis RT, et al. The correlation between carotid plaque ulceration and cerebral infarction seen on CT-scan. J Vasc Surg 1984;1:782-6.
26. Avril G, Batt M, Guidoin R, et al. Carotid endarterectomy: histopathological correlations. Ann Chir Vasc 1991;7:72-6.
27. Rekasem K, Shearman CP, Willians JA, Morris GE, Phillips MJ, Calder PC, et al. C-reactive protein is elevated in symptomatic compared with asymptomatic patients with carotid artery disease. Eur J Vasc Endovasc Surg 2002;23:505-9.
28. Canova CR, Courtin C, Reinhart WH. C-reactive protein (CRP) in cerebro-vascular events. Atherosclerosis 1999;147:49-53.
29. Yasojima K, Schwab C, McGeer E, McGeer P. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001;158:1039-51.
30. Virmani R, Burke AP, Kolodgie FD, Farb A. Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol 2002;15:439-46.
31. Wang TJ, Nam BH, Wilson PW, Wolf PA, Levy D, Polak JF, et al. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscl Thromb Vasc Biol 2002;22:1512-3.
32. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
33. Magyar MT, Szikszai Z, Balla Z, Valikovics A, Kappelmayer J, Imre S, et al. Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers. Stroke 2003;34:58-63.
34. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997;43:52-8.